「mentalhealth3」の検索結果
694件：21～25件目を表示
もしかして
-
General Announcement: September 6, 2024 Senju Pharmaceutical Co., Ltd. Launch of Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf -
Mytear EYETECT ALPITATTO | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® EYETECT® ALPITATTO Works on unpleasant eye itching due to pollens and o
https://www.senju.co.jp/english/products/ap.html -
General Announcement: September 6, 2024 Senju Pharmaceutical Co., Ltd. Launch of Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf -
General Announcement: July 26, 2024 Senju Pharmaceutical Co., Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinaf
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf